Transforming Wound Care with Graphene Sensors Each year, the NHS manages an estimated 2.2 million wounds at a cost of £5.3 billion. When wound microbial burden is not controlled, patients face a significant risk of sepsis, which remains the leading cause of mortality...
Biofilms in the Cystic Fibrosis Lung Biofilms pose a significant challenge in healthcare, responsible for approximately 80% of chronic and recurrent infections [1]. For individuals with cystic fibrosis (CF), biofilms in particular present a major problem. In the UK,...
Differentiating the Microbiome From a Biofilm Entities we refer to as biofilms and microbiomes are intrinsically intertwined with one another, however it is important to recognise that they are two distinct things. In this blog ‘Differentiating the Microbiome...
The Burden of Biofilms in the Food Industry Despite efforts to tackle pathogens within the food industry, foodborne illnesses still present a major problem globally. Attributable for 420,000 deaths annually, foodborne diseases pose a significant threat to human health...
Revolutionising Healthcare Cystic fibrosis (CF) is a genetic disease that affects around 11,000 people in the UK, and over 160,000 globally. One of the most important bugs that causes this is Pseudomonas aeruginosa – a bacterium that is present everywhere but rarely...
